SEC filings
Steris (STE)
Recent filings Steris made with the SEC, newest first. Most have a short AI-generated summary, and every one links to the original.
CIK 0001757898All filings on SEC.gov
10-QQuarterly report
Quarterly report
Steris reported higher revenue and operating income for the second quarter and first half of fiscal 2027, and said it agreed to acquire Xodus Medical for about $2.1 billion in cash plus up to $150 million in potential earnout…
8-KCurrent report
Entry into a Material Definitive Agreement; Termination of a Material Definitive Agreement …
STERIS plc entered into a new $1.6 billion revolving credit facility and a $500 million delayed draw term loan with J.P. Morgan SE and JPMorgan Chase Bank as administrative agents. …
8-KCurrent report
Results of Operations and Financial Condition; Costs Associated with Exit or Disposal Activities
STERIS reported fiscal 2027 second-quarter revenue of $1.6 billion, up 9% from a year earlier with 8% constant-currency organic growth, and raised its full-year adjusted earnings guidance to $11.35–$11.55 per diluted share from…
8-KCurrent report
Entry into a Material Definitive Agreement
On October 11, 2026, STERIS Corporation, a wholly owned subsidiary of STERIS plc, agreed to acquire all equity interests of Xodus Medical, Inc., a Pennsylvania-based specialty surgical products business, for $2.1 billion in cash at closing…
10-QQuarterly report
Quarterly report
Steris reported revenue of $1,492.7 million for the first three months of fiscal 2027, up 7.3% from $1,391.1 million a year earlier, while income from operations rose to $285.8 million from $246.0 million. …
8-KCurrent report
Submission of Matters to a Vote of Security Holders
At STERIS plc's 2026 annual general meeting, shareholders elected nine directors to one-year terms and reduced the board's size to nine members, ratified Ernst & Young LLP as independent auditor and Ernst & Young Chartered Accountants as…
8-K/AAmended current report
Amendment: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
8-KCurrent report
Results of Operations and Financial Condition; Costs Associated with Exit or Disposal Activities
Steris reported fiscal 2027 first quarter revenue up 7% to $1.5 billion with adjusted diluted EPS of $2.59, and announced a targeted consolidation plan moving U.S. …
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.
Follow Steris in Readster
Add Steris to your watchlist and its SEC filings reach your brief alongside the news about it, every line cited to its source. Readster also follows topics, people, newsletters and podcasts.
No credit card. When the trial ends, you move to Readster Free unless you subscribe.